StockData
Upstream Bio, Inc. logo

Upstream Bio, Inc. (UPB) stock

UPBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/30
$2.78−0.08 (-2.80%)

Close on Nov 13, 2026Market cap $152.26MP/E –Yield –

Upstream Bio statistics

67 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Mar 25, 2027 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$152.26M
$272.32M
Enterprise Value
-$55.10M
$146.23M
PS Ratio
53.05
3.66
PB Ratio
0.65
2.00
P/TBV Ratio
0.65
2.22

Enterprise valuationIndustry

EV / Sales
-19.20
2.57

Share statisticsIndustry

Shares Change (QoQ)
0.07%
0.50%
Float
50M
49M
Shares Held by Insiders
8.62%
11.7%
Shares Held by Institutions
92.3%
56.4%

Short sellingIndustry

Short Interest
4M
–
Short Interest Change
-20.8%
-0.80%
Short % of Float
7.09%
9.01%
Short % of Shares Outstanding
6.48%
6.30%
Days to Cover
2.70
5.15

Stock price statisticsIndustry

52-Week High
$33.68
–
52-Week Low
$2.68
–
20-Day Moving Average
$3.10
–
50-Day Moving Average
$4.24
–
200-Day Moving Average
$7.89
–
Average True Range (14)
$0.35
–
Price Change (1 Week)
-13.9%
-1.15%
Price Change (1 Month)
-17.5%
-4.87%
Price Change (3 Months)
-61.1%
-21.0%
Price Change (6 Months)
-69.4%
-20.6%
Price Change (YTD)
-89.8%
-23.6%
Price Change (1 Year)
-88.3%
-22.4%
Average Volume (10 Days)
1M
–
Average Volume (20 Days)
1M
–
Average Volume (90 Days)
836,425
–
Relative Volume
1.07
0.70
Relative Strength Index (14)
35.2
43.4
Volatility (1 Year)
92.9%
80.1%
Beta (5 Years)
1.28
1.07

MarginsIndustry

Operating Margin
-6116.0%
-38.7%
Profit Margin
-5712.3%
-31.6%
EBITDA Margin
-6108.9%
-27.7%

Returns on capitalIndustry

Return on Equity (ROE)
-53.5%
-49.9%
Return on Assets (ROA)
-51.5%
-40.6%
Return on Invested Capital (ROIC)
-846.4%
-32.9%
Return on Capital Employed (ROCE)
-75.0%
-37.9%

Financial positionIndustry

Current Ratio
20.45
3.30
Quick Ratio
17.37
2.39

GrowthIndustry

Revenue Growth (YoY)
2.54%
6.82%

EfficiencyIndustry

Asset Turnover
0.01
0.40
Revenue Per Employee
$38.27K
$429.29K
Profits Per Employee
-$2.19M
-$689.41K
Employee Count
75
74
WACC
11.5%
10.2%

Income statement (TTM)Industry

Revenue
$2.87M
$66.37M
Operating Income
-$175.53M
-$21.37M
Net Income
-$163.94M
-$22.35M
EBITDA
-$175.32M
-$17.21M
EPS (Diluted)
-$3.01
-$0.76

Balance sheetIndustry

Net Cash (Debt)
$207.37M
$17.76M
Net Cash Per Share
$3.79
$0.80
Equity (Book Value)
$233.98M
$53.89M
Book Value Per Share
$4.27
$1.50
Tangible Book Value
$233.98M
$27.13M
Working Capital
$232.67M
$79.99M

Cash flow (TTM)Industry

Operating Cash Flow
-$168.33M
-$12.38M

Dividends and yieldsIndustry

Earnings Yield
-107.7%
-21.8%

Taxes and interestIndustry

Income Tax
$0
$73.00K

Scores and fair valueIndustry

Altman Z-Score
3.80
0.23
Piotroski F-Score
1
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodUPBS&P 500DifferenceUPB per yearS&P 500 per year
1 month-21.7%-3.0%−18.7 pts
3 months-59.8%-2.8%−57.0 pts
Year to date-89.8%+11.5%−101.2 pts
1 year-88.1%+13.5%−101.6 pts

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

4M UPB shares were sold short on Oct 30, 2026, down 20.8% from the previous report, or 7.09% of the shares available to trade. At recent volumes it would take 2.7 days to buy them back. Over the last 20 sessions, 18.2% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20263,550,200-20.8%1,316,1862.7
Oct 15, 20264,480,785-0.8%1,215,6583.7
Sep 30, 20264,514,865+0.5%587,9667.7
Sep 15, 20264,490,724+9.7%656,1926.8
Aug 31, 20264,095,011+2.0%549,5037.5
Aug 14, 20264,016,614+10.1%712,3935.6
Jul 31, 20263,648,558+0.8%486,9617.5
Jul 15, 20263,618,151-11.9%442,0988.2
Jun 30, 20264,105,630+5.3%718,3385.7
Jun 15, 20263,898,229+7.1%711,4765.5
May 29, 20263,640,867+7.2%534,4046.8
May 15, 20263,397,759+5.4%507,8126.7

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?